RAPID: Positive Top-line Results for Etripamil Nasal Spray in Paroxysmal SVT | tctmd.com
Self-administered nasal spray 'rapidly' treats paroxysmal supraventricular tachycardia
NODE-301
Etripamil Nasal Spray Shows Promise for AF Patients With Rapid Ventricular Rate | tctmd.com
HRS 2017: Could etripamil nasal spray be a “game-changer” for paroxysmal supraventricular tachycardia? - Cardiac Rhythm News
A Nasal Spray for Rapid Heartbeat Disorder Could Be Best Option for Self-Treatment, Study Shows
:%0A%0AEtripamil%20Nasal%20Spray%20for%20Supraventricular%20Tachycardia.png?md=1 "Etripamil Nasal Spray for Supraventricular Tachycardia Clinical Trial 2023 | Power")
Etripamil Nasal Spray for Supraventricular Tachycardia Clinical Trial 2023 | Power
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology
Nasal spray shows potential for quickly treating arrhythmia
Etripamil Nasal Spray Shows Promising Phase III Results for PSVT Treatment - Xtalks
Etripamil Nasal Spray in Paroxysmal SVT Speeds Conversion to Sinus Rhythm: RAPID | tctmd.com
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm | Journal of the American College of Cardiology
Etripamil Nasal Spray Looks Promising for Self-Administered PSVT Treatment
Intranasal etripamil safe, effective for conversion of Paroxysmal supraventricular tachycardia to sinus rhythm
Milestone Pharmaceuticals' etripamil nasal spray meets primary endpoint of phase 3 trial in PSVT
Nasal Spray for Stopping PSVT Seems Feasible, Safe in Long Term
Etripamil Nasal Spray Reduced ER Vistsis and More PSVT Resolution in New NODE-301 Analysis | DAIC
NODE-302 Data Supports Etripamil Nasal Spray for PSVT Resolution
The role of self-administered intranasal etripamil in the management of SVT: the RAPID trial – BCS Heartbeat
Etripamil Nasal Spray For Acute Termination Of Spontaneous Episodes Of Paroxysmal Supraventricular Tachycardia. NODE-301 Trial
RAPID return to sinus rhythm after SVT using intranasal etripamil | Nature Reviews Cardiology
Etripamil | PDF
StudyPages - Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology
PDF) Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia
